Mission Bio

Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

Former Fortis Life Sciences CEO and private equity executive to drive expansion into clinical end markets and accelerate strategic biopharma collaborations SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Mission Bio, a leader in single-cell multiomic solutions for precision medicine, announced the appointment of Brian Kim as Chief Executive Officer. With over two decades of experience in the life sciences industry, he brings a unique combination of scientific innovation … Continue reading Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

VERNAL BIOSCIENCES

Vernal Biosciences Announces Strategic Leadership Appointments to Drive Growth in mRNA and LNP Formulation

COLCHESTER, Vt.–(BUSINESS WIRE)–Vernal Biosciences, a leading manufacturing and services company specializing in mRNA and lipid nanoparticle (LNP) formulation, proudly announces the additions of Sven Lee, Chief Commercial Officer, and Richard P. Hamel, Chief Financial Officer to its leadership team. Both distinguished leaders will strengthen Vernal’s position as a premier mRNA and LNP Contract Development and Manufacturing Organization (CDMO) while using their deep experience to deliver … Continue reading Vernal Biosciences Announces Strategic Leadership Appointments to Drive Growth in mRNA and LNP Formulation

Bruker

Bruker Acquires Electron Microscopy Company Nion

High-end STEM Technology Expands Bruker’s Portfolio for Materials Science Research BILLERICA, Mass.–(BUSINESS WIRE)–Bruker today announced that it has acquired Nion, a privately-held company that develops and manufactures innovative high-end scanning transmission electron microscopes (STEM). Nion was the first company to introduce aberration correction for STEM instruments with ultra-high stability for highest resolution images, and Nion is the world leader in ultra-high energy and spatial resolution electron … Continue reading Bruker Acquires Electron Microscopy Company Nion

Star Therapeutics

Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Star Therapeutics, a biotechnology company interrogating novel biology to develop life-changing therapies, today announced the appointment of Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer. Mr. Robertson brings more than twenty years of experience with corporate strategy, business operations, capital raising and M&A. “I’m very excited to join the Star Therapeutics team at a time of great momentum … Continue reading Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer

1910 GENETICS

1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director

Dr. Gandhi is VP and Head of Strategic Partnerships for Pfizer Ignite and will bring clinical, strategic and financial leadership to biotech’s board BOSTON–(BUSINESS WIRE)–1910 Genetics, the only biotech advancing small and large molecule drug discovery with an automated, multimodal AI platform, today announced the appointment of Shaan C. Gandhi, MD, DPhil, to its board of directors. Gandhi joins as an independent board director and … Continue reading 1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director

ArrivoBio

ArrivoBio Raises $45M in Series B Financing to Advance Pipeline

Funds will advance two novel drug candidates, SP-624 for major depressive disorder moving into late-stage development, and RABI-767 for the treatment of severe acute pancreatitis entering Phase 2 SP-624 is a first-in-class treatment activating SIRT6 for the treatment of major depression and other neuropsychiatric disorders MORRISVILLE, N.C.–(BUSINESS WIRE)–Arrivo BioVentures today announced the closing of an oversubscribed Series B preferred financing round, totaling $45.25 million in committed … Continue reading ArrivoBio Raises $45M in Series B Financing to Advance Pipeline

CNA

MARYANN SURRICK NAMED AS GENERAL COUNSEL AT CNA

Monday, October 9, 2023 – Arlington, VA CNA welcomes Maryann Surrick to CNA as its new general counsel and senior vice president. Surrick is a top-tier government contracts attorney with experience working for both a nonprofit organization and a Fortune 50 corporation. Most recently, Surrick served as general counsel for The Sentry, an international human rights NGO. She previously was an executive-level in-house lawyer at … Continue reading MARYANN SURRICK NAMED AS GENERAL COUNSEL AT CNA

Tevogen Bio

Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative

October 23, 2023 04:35 PM Eastern Daylight Time WARREN, N.J.–(BUSINESS WIRE)–Tevogen Bio Inc. (“Tevogen Bio”) today announced the appointment of Mittul Mehta as Chief Information Officer (CIO) and Head of Tevogen.ai, the newly launched initiative focused on harnessing the potential of artificial intelligence (AI) for the enhancement of drug discovery, development, manufacturing, distribution, and patient access. “I am excited to join Tevogen Bio at such a … Continue reading Tevogen Bio Appoints IT Expert and Leader Mittul Mehta as Chief Information Officer and Head of Tevogen.ai Initiative